# abrdn Silver ETF Trust: financial statements, quarterly

SIVR · NYSE · CIK 1450922 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sivr.md) · [Financials](/companies/sivr/financials.md) · [Filings](/companies/sivr/filings.md) · [Insiders](/companies/sivr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sivr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [27.7](/filings/0001999371-24-014551.md) | [32.3 d](/filings/0001999371-26-004973.md) | [32.5](/filings/0001999371-25-005708.md) | [216](/filings/0001999371-25-010852.md) | [79.8](/filings/0001999371-25-017270.md) | [(113) d](/filings/0001999371-26-004973.md) | [247](/filings/0001999371-26-010350.md) | [100](/filings/0001999371-26-017415.md) | [624](/filings/0001999371-25-017270.md) | [1,866 d](/filings/0001999371-26-004973.md) | [112](/filings/0001999371-26-010350.md) | [(947)](/filings/0001999371-26-017415.md) |
| Basic EPS | $ per share | [0.57](/filings/0001999371-24-014551.md) | not reported | [0.69](/filings/0001999371-25-005708.md) | [4.58](/filings/0001999371-25-010852.md) | [1.65](/filings/0001999371-25-017270.md) | not reported | [4.88](/filings/0001999371-26-010350.md) | [1.88](/filings/0001999371-26-017415.md) | [9.99](/filings/0001999371-25-017270.md) | not reported | [1.46](/filings/0001999371-26-010350.md) | [(13.10)](/filings/0001999371-26-017415.md) |

- Gross profit: not reported
- Net income: us-gaap:NetIncomeLoss
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [1,045](/filings/0001839882-23-030155.md) | [1,061](/filings/0001839882-25-012450.md) | [1,096](/filings/0001999371-24-005864.md) | [1,337](/filings/0001999371-24-009838.md) | [1,454](/filings/0001999371-24-014551.md) | [1,421](/filings/0001999371-26-004973.md) | [1,641](/filings/0001999371-25-005708.md) | [1,983](/filings/0001999371-25-010852.md) | [3,005](/filings/0001999371-25-017270.md) | [5,432](/filings/0001999371-26-017415.md) | [4,972](/filings/0001999371-26-010350.md) | [3,952](/filings/0001999371-26-017415.md) |
| Total liabilities | $m | [0.3](/filings/0001839882-23-030155.md) | [0.3](/filings/0001839882-25-012450.md) | [0.3](/filings/0001999371-24-005864.md) | [0.3](/filings/0001999371-24-009838.md) | [0.4](/filings/0001999371-24-014551.md) | [0.4](/filings/0001999371-26-004973.md) | [0.4](/filings/0001999371-25-005708.md) | [0.5](/filings/0001999371-25-010852.md) | [0.7](/filings/0001999371-25-017270.md) | [1.4](/filings/0001999371-26-017415.md) | [1.3](/filings/0001999371-26-010350.md) | [1.0](/filings/0001999371-26-017415.md) |
| Shareholders' equity | $m | [1,045](/filings/0001999371-24-014551.md) | [1,060](/filings/0001999371-26-004973.md) | [1,095](/filings/0001999371-25-010852.md) | [1,337](/filings/0001999371-25-017270.md) | [1,453](/filings/0001999371-25-017270.md) | [1,421](/filings/0001999371-26-017415.md) | [1,641](/filings/0001999371-26-017415.md) | [1,982](/filings/0001999371-26-017415.md) | [3,004](/filings/0001999371-25-017270.md) | [5,430](/filings/0001999371-26-017415.md) | [4,970](/filings/0001999371-26-017415.md) | [3,951](/filings/0001999371-26-017415.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2011-03-31) | Q2 FY2011 (2011-06-30) | Q3 FY2011 (2011-09-30) | Q4 FY2011 (2011-12-31) | Q1 FY2012 (2012-03-31) | Q2 FY2012 (2012-06-30) | Q3 FY2012 (2012-09-30) | Q4 FY2012 (2012-12-31) | Q1 FY2013 (2013-03-31) | Q2 FY2013 (2013-06-30) | Q3 FY2013 (2013-09-30) | Q4 FY2013 (2013-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [0.0](/filings/0000930413-12-002978.md) | [0.0](/filings/0000930413-12-004461.md) | [0.0](/filings/0001450922-12-000003.md) | [0.0 d](/filings/0001450922-14-000005.md) | [0.0](/filings/0001450922-13-000008.md) | [0.0](/filings/0001450922-13-000021.md) | [0.0](/filings/0001450922-13-000024.md) | [0.0 d](/filings/0001450922-15-000002.md) | [0.0](/filings/0001450922-14-000011.md) | [0.0](/filings/0001450922-14-000030.md) | [0.0](/filings/0001450922-14-000049.md) | [0.0 d](/filings/0001450922-16-000014.md) |
| Share repurchases | $m | [(11.3)](/filings/0000930413-12-002978.md) | [113](/filings/0000930413-12-004461.md) | [91.9](/filings/0001450922-12-000003.md) | [22.7 d](/filings/0001450922-14-000005.md) | [22.9](/filings/0001450922-13-000008.md) | [38.5](/filings/0001450922-13-000021.md) | [0.0](/filings/0001450922-13-000024.md) | [3.4 d](/filings/0001450922-15-000002.md) | [3.2](/filings/0001450922-14-000011.md) | [17.7](/filings/0001450922-14-000030.md) | [7.8](/filings/0001450922-14-000049.md) | [4.3 d](/filings/0001450922-16-000014.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

Shares outstanding: 71,150,000 at 2026-08-05, from the cover of the [10-Q filed 2026-08-07](/filings/0001999371-26-017415.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.